Kodiak Sciences präsentiert sich auf drei Investorenkonferenzen
- Kodiak Sciences nimmt mit CEO Victor Perlroth im November und Dezember 2026 an drei Investorenkonferenzen teil.
- Jefferies Global Healthcare Conference am 16. November 2026 in London; UBS Global Biopharma Conference am 17. November 2026 ebenfalls dort.
- Am 1. Dezember 2026 folgt die 9. Annual Evercore Healthcare Conference in Miami.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kodiak Sciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611111843PR_NEWS_USPR_____SF94849) on November 11, 2026, and is solely responsible for the information contained therein.